ATXS vs KMB · rev $706.0K vs P/E 19, rev $8.35B
Astria Therapeutics Inc (ATXS) versus Kimberly-Clark Corporation (KMB) — a side-by-side from cached financials, not a winner call.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
Kimberly-Clark Corporation (KMB) is a household & personal products company listed on US.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
Latest reported KMB revenue for 2026-06-30 was $8.35B. Net income was $1.01B. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
ATXS currently screens at market cap $382.1M. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
Not investment advice. Open the ATXS and KMB stock pages for the full models.
Not investment advice.